ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

Adding Ultrasound Revealed More Breast Cancers In Study

May 30, 2008

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993